Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion - Discussion
Other
Sparks, S; Shortell, CK
Published in: JOURNAL OF VASCULAR SURGERY
November 2001
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JOURNAL OF VASCULAR SURGERY
ISSN
0741-5214
Publication Date
November 2001
Volume
34
Issue
5
Start / End Page
859 / 859
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sparks, S., & Shortell, C. K. (2001). Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion - Discussion. JOURNAL OF VASCULAR SURGERY.
Sparks, S., and C. K. Shortell. “Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion - Discussion.” JOURNAL OF VASCULAR SURGERY, November 2001.
Sparks S, Shortell CK. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion - Discussion. Vol. 34, JOURNAL OF VASCULAR SURGERY. 2001. p. 859–859.
Sparks, S., and C. K. Shortell. “Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion - Discussion.” JOURNAL OF VASCULAR SURGERY, vol. 34, no. 5, Nov. 2001, pp. 859–859.
Sparks S, Shortell CK. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion - Discussion. JOURNAL OF VASCULAR SURGERY. 2001. p. 859–859.
Published In
JOURNAL OF VASCULAR SURGERY
ISSN
0741-5214
Publication Date
November 2001
Volume
34
Issue
5
Start / End Page
859 / 859
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology